483
Merck & CieFDA 483 - Merck & Cie - November 02, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an inspection of Merck & Cie, an API manufacturer in Schaffhausen, Switzerland, the FDA observed significant deficiencies in the control of computer and laboratory systems. Specifically, laboratory personnel were assigned administrator roles allowing data manipulation, and the chromatographic software lacked essential audit trail capabilities. These findings indicate a lack of appropriate controls over electronic raw data and potential data integrity issues.
Open in Dashboard
ID · 4dc6a2a1-e793-4f85-945b-f6bb9c135cac